Pharma industry's code of practice violations leave UK regulator unmoved
This article was originally published in SRA
Executive Summary
UK drug regulators remain sanguine in the face of claims that self-regulation by the pharmaceutical industry of its promotional and marketing practices is failing after a study found that companies violate their codes of practice time and again. The pharmaceutical industry for its part claims the study is proof the "system of self-regulation is working and effective".